Hope Tempered by Caution: Public Beliefs in the USA about the Benefits and Drawbacks of Using Epigenetic Technologies in Clinical Care
Public Health Genomics · 05.08.2026 · 29 (1) · 278-288
DOI: 10.1159/phg/aenag003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Public Health Genomics, online erschienen am 05.08.2026. Verfasst von Erika A Waters und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Public Health Sciences, Department of Surgery, Washington University in St. Louis, St. Louis, USA, waterse@wustl.edu. Hauptthemen laut MEDLINE: Public Opinion, Epigenomics, Epigenesis, Genetic. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, NIEHS NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Introduction
Clinical applications of epigenetic technologies could revolutionize precision medicine. However, successful uptake in clinical settings may be influenced by public opinion. We investigated public beliefs about possible benefits and drawbacks of epigenetic-based medical technologies.
Methods
We recruited 153 adults from across the USA to participate in 1 of 27 virtual focus groups, each lasting 45–75 min. Groups were stratified by education (less than bachelor’s degree vs. bachelor’s degree or more) and race and ethnicity (black or African American, Asian, Indigenous [Native Hawaiian, Pacific Islander, American Indian, Alaska Native], Hispanic, and white). Participants viewed an educational video about epigenetics prior to discussion. We used inductive and deductive qualitative content analysis.
Results
Participants indicated that epigenetic technologies could be used to guide risk-stratified prevention (i.e., engage in behaviors to reduce the risk of developing a health condition; engage in screening and early-detection behaviors to enable early treatment; facilitate clinical history-taking; inform reproductive planning decisions) and to develop novel therapeutics and editing approaches (i.e., new medications; epigenetic editing). However, participants also mentioned concerns about the ethical, legal, and social implications (ELSIs) of epigenetics, including exacerbating health disparities; the high cost of treatment and health insurance; promoting eugenics; and epigenetic-based discrimination by healthcare providers. Each of the race, education, and ethnicity strata included content related to each of the three major subthemes of risk-stratified prevention, novel therapeutics, and ELSI considerations.
Conclusion
Efforts to translate basic epigenetics research to clinical practice hold promise, but it is also critical to create solutions that address people’s concerns.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Public Health Sciences, Department of Surgery, Washington University in St. Louis, St. Louis, USA, waterse@wustl.edu.
- Division of Public Health Sciences, Department of Surgery, Washington University in St. Louis, St. Louis, USA.
- Department of Social and Behavioral Sciences, Yale School of Public Health, New Haven, USA.
- Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, USA.
- Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.
- Division of General Medicine and Geriatrics, Bioethics Research Center, Washington University in St. Louis, St. Louis, USA.
Förderung
- NCI NIH HHS
- NIEHS NIH HHS
- NCATS NIH HHS
Zitieren
APA
Waters, E. A., Yuen, C., Gaona Romero, C., Maki, J., Takenaka, B. P., Raisa, A., Linnenbringer, E., Hamilton, J. G., Mozersky, J., Souroullas, G. P., & Carter, C. R. (2026). Hope Tempered by Caution: Public Beliefs in the USA about the Benefits and Drawbacks of Using Epigenetic Technologies in Clinical Care. Public Health Genomics, 29(1), 278-288. https://doi.org/10.1159/phg/aenag003
Vancouver
Waters EA, Yuen C, Gaona Romero C, Maki J, Takenaka BP, Raisa A, et al. Hope Tempered by Caution: Public Beliefs in the USA about the Benefits and Drawbacks of Using Epigenetic Technologies in Clinical Care. Public Health Genomics. 2026;29(1):278-288. doi:10.1159/phg/aenag003
BibTeX
@article{Waters2026,
author = {Waters, Erika A and Yuen, Caitlin and Gaona Romero, Clarissa and Maki, Julia and Takenaka, Bryce Puesta and Raisa, Aantaki and Linnenbringer, Erin and Hamilton, Jada G and Mozersky, Jessica and Souroullas, George P and Carter, Chelsey R},
title = {Hope Tempered by Caution: Public Beliefs in the USA about the Benefits and Drawbacks of Using Epigenetic Technologies in Clinical Care},
journal = {Public Health Genomics},
year = {2026},
volume = {29},
number = {1},
pages = {278--288},
doi = {10.1159/phg/aenag003}
}
EUVIMED